Thailand might order 200,000 courses of anti-COVID drugs from Merck
Category: #health  | By Mateen Dalal  | Date: 2021-10-05 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Thailand might order 200,000 courses of anti-COVID drugs from Merck

Thailand’s government is reportedly in talks with U.S. Pharmaceutical giant Merck & Co. to order 200,000 courses of the company’s experimental anti-viral COVID pills.

Confirming the news, the Director-general of the Department of Medical Services of Thailand, Somsak Akksilp stated that the country is presently working on a buying agreement for the medicine. He further said that a consignment of 200,000 courses has been pre-booked and is likely to arrive by December.

Notably, the drug will be made available for public use only after it receives due approval from the U.S. Food and Drug Administration (FDA) as well as the Thai regulator, added Akksilp.

Several Asian countries are trying to get their hands on this potential treatment after falling behind other Western nations in vaccine procurement, due to the acute pinch in supply volumes.

Sources claim that Malaysia, Taiwan, and South Korea are in the queue to buy the new drug from Merck. Meanwhile, the Philippines has already begun a trial on these pills and hopes for it to show efficient results.

Maria Rosario Vergeire, Health Undersecretary of the Philippines was quoted saying that the nation is eligible to have higher access to this treatment as they have the scientific trial counterpart.

The anti-COVID drug, known as molnupiravir is the first-ever oral medication for the treatment of coronavirus disease. Interim trials suggest that it could reduce the chance of death or hospitalization in high-risk patients by 50%. According to sources, the pill works by introducing errors to the genetic code of the virus.

Merck is anticipating a production volume of at least 10 million courses of this antiviral drug by the end of the year. The company recently announced an agreement to supply 1.7 million courses at a price of USD 700 each to the U.S government.

The pharma giant has also stated that the cost of the medicine will be based on the level of income in each of the nations.

Source credits-

https://kfgo.com/2021/10/04/thailand-in-talks-with-merck-for-200000-courses-of-anti-covid-pills/

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

Apollo plans to expand looking at average occupancy surge

Apollo plans to expand looking at average occupancy surge

By Mateen Dalal

Apollo Hospitals Enterprises Ltd., one of India's leading healthcare providers, is reportedly targeting to increase the average occupancy rate in its hospitals to 68-70% for the fiscal year 2024. The company recently announced impressive finan...

ChatGPT’s creator OpenAI proposes regulation of AI by humans

ChatGPT’s creator OpenAI proposes regulation of AI by humans

By Mateen Dalal

OpenAI, the creator of ChatGPT, has reportedly put forward a proposal for the establishment of an international organization to regulate artificial intelligence (AI). Led by CEO Sam Altman, the company believes that AI systems developed within the ne...

Medtronic pledges USD 350 Mn to expand R&D operations in India

Medtronic pledges USD 350 Mn to expand R&D operations in India

By Mateen Dalal

Medtronic, a leading healthcare technology company, has announced plans to expand its R&D center in Hyderabad, India, with a whopping investment of USD 350 million. The existing facility is already the largest center for the company outside the U...